Will the real multiple sclerosis please stand up? (Q38020092)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

5 February 2020

title

Will the real multiple sclerosis please stand up? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

5 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Peter K Stys

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

5 February 2020

Jan van Minnen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

5 February 2020

Jeroen J G Geurts

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

20 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

Nature Reviews Neuroscience

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

5 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

5 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

507-514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

Multiple sclerosis--the plaque and its pathogenesis

31 March 2020

1 reference

Gray matter pathology in (chronic) MS: modern views on an early observation

31 March 2020

1 reference

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

31 March 2020

1 reference

Neurodegeneration in autoimmune CNS inflammation

31 March 2020

1 reference

Disease-modifying agents for multiple sclerosis: recent advances and future prospects

31 March 2020

1 reference

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

31 March 2020

1 reference

Multiple sclerosis: an immune or neurodegenerative disorder?

31 March 2020

1 reference

Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis

31 March 2020

1 reference

Ultrastructure of multiple sclerosis

31 March 2020

1 reference

Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.

31 March 2020

1 reference

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

31 March 2020

1 reference

Multiple sclerosis: distribution of inflammatory cells in newly forming lesions

31 March 2020

1 reference

Innate and adaptive autoimmunity directed to the central nervous system

31 March 2020

1 reference

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

31 March 2020

1 reference

Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?

31 March 2020

1 reference

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions

31 March 2020

1 reference

Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis

31 March 2020

1 reference

Axonal Transection in the Lesions of Multiple Sclerosis

31 March 2020

1 reference

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

31 March 2020

1 reference

Ageing and immunity: addressing immune senescence to ensure healthy ageing

31 March 2020

1 reference

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

31 March 2020

1 reference

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis

31 March 2020

1 reference

The effect of cladribine on T(1) 'black hole' changes in progressive MS.

31 March 2020

1 reference

Progressive multiple sclerosis: characteristics and management

31 March 2020

1 reference

Autologous haematopoietic stem-cell transplantation in multiple sclerosis

31 March 2020

1 reference

Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis

31 March 2020

1 reference

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis

31 March 2020

1 reference

Neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation

31 March 2020

1 reference

Pathophysiology of inflammation and tissue injury in multiple sclerosis: what are the targets for therapy

31 March 2020

1 reference

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

31 March 2020

1 reference

Age at disability milestones in multiple sclerosis

31 March 2020

1 reference

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

31 March 2020

1 reference

The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis

31 March 2020

1 reference

Lipid microarrays identify key mediators of autoimmune brain inflammation

31 March 2020

1 reference

Marburg type and Bal�?s concentric sclerosis: rare and acute variants of multiple sclerosis

31 March 2020

1 reference

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

31 March 2020

1 reference

At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only

31 March 2020

1 reference

Relapses and progression of disability in multiple sclerosis

31 March 2020

1 reference

Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials

31 March 2020

1 reference

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial

31 March 2020

1 reference

Experimental models of multiple sclerosis

31 March 2020

1 reference

Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis

31 March 2020

1 reference

Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation

31 March 2020

1 reference

Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.

31 March 2020

1 reference

Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy

31 March 2020

1 reference

The epidemiology of Leber hereditary optic neuropathy in the North East of England

31 March 2020

1 reference

The changing demographic pattern of multiple sclerosis epidemiology

31 March 2020

1 reference

The epidemiology of autoimmune diseases

31 March 2020

1 reference

Neuropathology of white matter disease in Leber's hereditary optic neuropathy

31 March 2020

1 reference

The cuprizone animal model: new insights into an old story

31 March 2020

1 reference

CNS demyelination associated with copper deficiency and hyperzincemia

31 March 2020

1 reference

Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors

31 March 2020

1 reference

Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.

31 March 2020

1 reference

NMDA receptors are expressed in oligodendrocytes and activated in ischaemia.

31 March 2020

1 reference

NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia

31 March 2020

1 reference

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury

31 March 2020

1 reference

Metabolic injury to axons and myelin

31 March 2020

1 reference

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes.

31 March 2020

1 reference

Gray matter atrophy in multiple sclerosis: a longitudinal study

31 March 2020

1 reference

31 March 2020

The axo-myelinic synapse

1 reference

Primary oligodendrocyte death does not elicit anti-CNS immunity

31 March 2020

1 reference

Multiple system atrophy: a primary oligodendrogliopathy.

31 March 2020

1 reference

A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease

31 March 2020

1 reference

Citrullinated myelin basic protein induces experimental autoimmune encephalomyelitis in Lewis rats through a diverse T cell repertoire

31 March 2020

1 reference

Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein

31 March 2020

1 reference

Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities

31 March 2020

1 reference

Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes

31 March 2020

1 reference

Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation

31 March 2020

1 reference

Absence of perforin expression confers axonal protection despite demyelination.

31 March 2020

1 reference

Multiple sclerosis - candidate mechanisms underlying CNS atrophy

31 March 2020

1 reference

Glutamate and ATP signalling in white matter pathology

31 March 2020

1 reference

Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

31 March 2020

1 reference

Mitochondrial changes within axons in multiple sclerosis

31 March 2020

1 reference

Imaging correlates of decreased axonal Na /K ATPase in chronic multiple sclerosis lesions.

31 March 2020

1 reference

Axonal degeneration in multiple sclerosis: is it time for neuroprotective strategies?

31 March 2020

1 reference

Schwann cell to axon transfer of ribosomes: toward a novel understanding of the role of glia in the nervous system.

31 March 2020

1 reference

Defining the clinical course of multiple sclerosis: Results of an international survey

31 March 2020

1 reference

Primary-progressive multiple sclerosis

31 March 2020

1 reference

Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment

31 March 2020

1 reference

Inflammation and Alzheimer's disease

31 March 2020

1 reference

Inflammation as a causative factor in the aetiology of Parkinson's disease

31 March 2020

1 reference

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

31 March 2020

1 reference

Inflammation and neurodegeneration in Parkinson's disease

31 March 2020

1 reference

Senescence of the human immune system

31 March 2020

1 reference

Immunopathogenesis of multiple sclerosis

31 March 2020

1 reference

Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22714021

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22714021

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRN3275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 February 2020

1044502578

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714021 AND SRC:MED&resulttype=core&format=json